BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2014
View Archived Issues
Novel genetic variants associated with susceptibility to anorexia nervosa
Read More
Novel biological candidate SM-101 shows promise in phase II trials in patient with SLE
Read More
FDA grants imiquimod orphan status for carcinoma in situ of the urinary bladder
Read More
Liposome encapsulated paclitaxel receives U.S. orphan designation for gastric cancer
Read More
Neurocrine Biosciences begins phase I/II trial of NBI-77860
Read More
Nihon Medi-Physics patents Abeta imaging agents
Read More
International PANACEA study opens in patients with HER2+ breast cancer
Read More
Phase II data for sotatercept as treatment of anemia in hemodialysis subjects
Read More
PF-06747143: a novel CXCR4 antagonist antibody for the treatment of hematological malignancies
Read More
Clinical studies of lucitanib in breast cancer
Read More
Karyopharm begins third registration-directed trial of selinexor
Read More
Taiho Pharmaceutical divulges PKB inhibitors
Read More
Oral Health Australia reports propeptides for periodontal diseases
Read More
Novel vinca alkaloids presented by Gedeon Richter
Read More
Noribogaine HCl safe and well tolerated in healthy volunteers
Read More
Plexxikon and QuantumLeap select PLX-3397 for I-SPY 2 TRIAL in breast cancer
Read More
FDA accepts IND application for AGT-182 for the treatment of Hunter syndrome
Read More
Pieris begins phase I study of Anticalin to treat anemia
Read More
NIHR confirms start of study to test new drug for Sjogren's syndrome
Read More
CardioKinetix signs agreement with Edwards Lifesciences
Read More
FDA grants conditional approval to Cytori Cell Therapy for trial in scleroderma
Read More
FDA approves Quidel's AmpliVue Bordetella Assay
Read More
Navidea establishes Macrophage Therapeutics to develop drugs targeting activated macrophages
Read More
Lakewood-Amedex submits IND application for phase I/II trial of Nu-3 in diabetic foot ulcer
Read More
FDA approves MP Biomedicals' test to confirm HTLV-I/II antibodies
Read More
Geneva team pauses VSV-ZEBOV vaccinations following cases of joint pain
Read More